{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:24:41Z","timestamp":1720830281998},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"DOI":"10.7759\/cureus.64429","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T19:44:16Z","timestamp":1720813456000},"source":"Crossref","is-referenced-by-count":0,"title":["Preventive Antibiotic Use and Complications After Endoscopic Retrograde Cholangiopancreatography in Patients Hospitalized for Primary Sclerosing Cholangitis"],"prefix":"10.7759","author":[{"given":"Fidelis E","family":"Uwumiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon  O","family":"Anighoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael   M","family":"Bojerenu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nsikan N","family":"Akpabio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel U","family":"Asogwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victory","family":"Okpujie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Alemenzohu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osarumwense  D","family":"Ufuah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miracle C","family":"Okoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihunanya M","family":"Kanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tosin","family":"Ayantoyinbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ridwan A","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2019.03.004","article-title":"Biliary endoscopy in the management of primary sclerosing cholangitis and its complications","volume":"3","author":"Fung BM","year":"2019","unstructured":"Fung BM, Tabibian JH. Biliary endoscopy in the management of primary sclerosing cholangitis and its complications. Liver Res. 2019, 3:106-17. 10.1016\/j.livres.2019.03.004","journal-title":"Liver Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline","volume":"49","author":"Aabakken L","year":"2017","unstructured":"Aabakken L, Karlsen TH, Albert J, et al.. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy. 2017, 49:588-608. 10.1055\/s-0043-107029","journal-title":"Endoscopy"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2372257","article-title":"ERCP-related adverse events in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"2022","author":"Natt N","year":"2022","unstructured":"Natt N, Michael F, Michael H, Dubois S, Al Mazrou'i A. ERCP-related adverse events in primary sclerosing cholangitis: a systematic review and meta-analysis. Can J Gastroenterol Hepatol. 2022, 2022:2372257. 10.1155\/2022\/2372257","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor KD","year":"2015","unstructured":"Lindor KD, Kowdley KV, Harrison ME. ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015, 110:646-59; quiz 660. 10.1038\/ajg.2015.112","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0195-6701(91)90169-9","article-title":"Prevention of sepsis following endoscopic retrograde cholangiopancreatography","volume":"65","author":"Alveyn CG","year":"1991","unstructured":"Alveyn CG, Robertson DA, Wright R, Lowes JA, Tillotson G. Prevention of sepsis following endoscopic retrograde cholangiopancreatography. J Hosp Infect. 1991, 65:70. 10.1016\/0195-6701(91)90169-9","journal-title":"J Hosp Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-017-0290-0","article-title":"Post-ERCP infection and its epidemiological and clinical characteristics in a large Chinese tertiary hospital: a 4-year surveillance study","volume":"6","author":"Du M","year":"2017","unstructured":"Du M, Suo J, Liu B, Xing Y, Chen L, Liu Y. Post-ERCP infection and its epidemiological and clinical characteristics in a large Chinese tertiary hospital: a 4-year surveillance study. Antimicrob Resist Infect Control. 2017, 6:131. 10.1186\/s13756-017-0290-0","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1527328","article-title":"Microbial profiles and risk factors of preexisting biliary infection in patients with therapeutic endoscopy","volume":"2019","author":"Ruan HQ","year":"2019","unstructured":"Ruan HQ, Liao GL, Peng P, et al.. Microbial profiles and risk factors of preexisting biliary infection in patients with therapeutic endoscopy. Gastroenterol Res Pract. 2019, 2019:1527328. 10.1155\/2019\/1527328","journal-title":"Gastroenterol Res Pract"},{"key":"ref8","article-title":"Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them","volume":"9","author":"Szary NM","year":"2013","unstructured":"Szary NM, Al-Kawas FH. Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them. Gastroenterol Hepatol (N Y). 2013, 9:496-504.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4253\/wjge.v14.i11.718","article-title":"Antibiotic prophylaxis to prevent complications in endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Merchan MF","year":"2022","unstructured":"Merchan MF, de Moura DT, de Oliveira GH, et al.. Antibiotic prophylaxis to prevent complications in endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis of randomized controlled trials. World J Gastrointest Endosc. 2022, 14:718-30. 10.4253\/wjge.v14.i11.718","journal-title":"World J Gastrointest Endosc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0570-4","article-title":"Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study","volume":"17","author":"Wobser H","year":"2017","unstructured":"Wobser H, Gunesch A, Klebl F. Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study. BMC Gastroenterol. 2017, 17:10. 10.1186\/s12876-017-0570-4","journal-title":"BMC Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2014.08.008","article-title":"Antibiotic prophylaxis for GI endoscopy","volume":"81","author":"Khashab MA","year":"2015","unstructured":"Khashab MA, Chithadi KV, Acosta RD, et al.. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2015, 81:81-9. 10.1016\/j.gie.2014.08.008","journal-title":"Gastrointest Endosc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/a-1075-4080","article-title":"ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"52","author":"Dumonceau JM","year":"2020","unstructured":"Dumonceau JM, Kapral C, Aabakken L, et al.. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020, 52:127-49. 10.1055\/a-1075-4080","journal-title":"Endoscopy"},{"key":"ref13","unstructured":"NIS Database Documentation. Healthcare Cost and Utilization Project. (2023). Accessed. March 5, 2023: https:\/\/www.hcupus.ahrq.gov\/db\/nation\/nis\/NIS_Introduction_2018.jsp."},{"key":"ref14","unstructured":"Medicare Advantage in 2023. Enrollment Update and Key Trends. (2022). Accessed: March 5, 2023: https:\/\/www.kff.org\/medicare\/issue-brief\/medicare-advantage-in-2023-enrollment-update-and-key-trends\/."},{"key":"ref15","unstructured":"National Bureau of Economic Research. Guidance. Data sets not requiring IRB Review. NBER. (2024). Accessed: May 23, 2024: https:\/\/www.nber.org\/programs-projects\/projects-and-centers\/human-subjects-protection-and-institutional-review-board-...."},{"key":"ref16","unstructured":"Nationwide Data Use Agreement-HCUP. (2022). Accessed. March 5, 2023: https:\/\/www.hcup-us.ahrq.gov\/team\/NationwideDUA.jsp."},{"key":"ref17","unstructured":"How Can Covered Entities Use and Disclose Protected Health Information for Research and Comply with the Privacy Rule?\u00a0. (2007). Accessed. March 5, 2023: https:\/\/privacyruleandresearch.nih.gov\/pr_08.asp.."},{"key":"ref18","unstructured":"Charlson Comorbidity Index (CCI)\u2014Strokengine. (2023). Accessed. April 23, 2023: https:\/\/strokengine.ca\/en\/assessments\/charlson-comorbidity-index-cci\/."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo RA","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992, 45:613-9. 10.1016\/0895-4356(92)90133-8","journal-title":"J Clin Epidemiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-022-01805-3","article-title":"All patient refined-diagnosis related groups\u2019 (Apr-DRGs) severity of illness and risk of mortality as predictors of in-hospital mortality","volume":"46","author":"Santos JV","year":"2022","unstructured":"Santos JV, Viana J, Pinto C, Souza J, Lopes F, Freitas A, Lopes S. All patient refined-diagnosis related groups\u2019 (Apr-DRGs) severity of illness and risk of mortality as predictors of in-hospital mortality. J Med Syst. 2022, 46:37. 10.1007\/s10916-022-01805-3","journal-title":"J Med Syst"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000788","article-title":"Accuracy of International Classification of Diseases, 10th revision codes for identifying sepsis: a systematic review and meta-analysis","volume":"4","author":"Liu B","year":"2022","unstructured":"Liu B, Hadzi-Tosev M, Liu Y, et al.. Accuracy of International Classification of Diseases, 10th revision codes for identifying sepsis: a systematic review and meta-analysis. Crit Care Explor. 2022, 4:e0788. 10.1097\/CCE.0000000000000788","journal-title":"Crit Care Explor"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0847-3","article-title":"Validity of administrative data in recording sepsis: a systematic review","volume":"19","author":"Jolley RJ","year":"2015","unstructured":"Jolley RJ, Sawka KJ, Yergens DW, Quan H, Jett\u00e9 N, Doig CJ. Validity of administrative data in recording sepsis: a systematic review. Crit Care. 2015, 19:139. 10.1186\/s13054-015-0847-3","journal-title":"Crit Care"},{"key":"ref23","article-title":"Accuracy of international classification of diseases, 10th revision codes for identifying severe sepsis in patients admitted from the emergency department","volume":"14","author":"Ibrahim I","year":"2012","unstructured":"Ibrahim I, Jacobs IG, Webb SA, Finn J. Accuracy of international classification of diseases, 10th revision codes for identifying severe sepsis in patients admitted from the emergency department. Crit Care Resusc. 2012, 14:112-8.","journal-title":"Crit Care Resusc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/01973533.2016.1277529","article-title":"Extracting the variance inflation factor and other multicollinearity diagnostics from typical regression results, basic and applied","volume":"39","author":"Christopher GT","year":"2017","unstructured":"Christopher GT, Rae SK, Ariel MA, Betsy JB. Extracting the variance inflation factor and other multicollinearity diagnostics from typical regression results, basic and applied. Social Psychology Proc. 2017, 39:81-90. 10.1080\/01973533.2016.1277529","journal-title":"Social Psychology Proc"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4097\/kja.19087","article-title":"Multicollinearity and misleading statistical results","volume":"72","author":"Kim JH","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019, 72:558-69. 10.4097\/kja.19087","journal-title":"Korean J Anesthesiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.21037\/tgh.2018.05.04","article-title":"Does \"July effect\" exist in colonoscopies performed at teaching hospitals?","volume":"3","author":"Desai R","year":"2018","unstructured":"Desai R, Patel U, Goyal H. Does \"July effect\" exist in colonoscopies performed at teaching hospitals?. Transl Gastroenterol Hepatol. 2018, 3:28. 10.21037\/tgh.2018.05.04","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.12.043","article-title":"Alarming increasing trends in hospitalizations and mortality with Heyde\u2019s syndrome: a nationwide inpatient perspective (2007 to 2014)","volume":"123","author":"Desai R","year":"2019","unstructured":"Desai R, Parekh T, Singh S, et al.. Alarming increasing trends in hospitalizations and mortality with Heyde\u2019s syndrome: a nationwide inpatient perspective (2007 to 2014). Am J Cardiol. 2019, 123:1149-55. 10.1016\/j.amjcard.2018.12.043","journal-title":"Am J Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.21037\/cdt.2018.09.02","article-title":"Racial and sex disparities in resource utilization and outcomes of multi-vessel percutaneous coronary interventions (a 5-year nationwide evaluation in the United States)","volume":"9","author":"Desai R","year":"2019","unstructured":"Desai R, Singh S, Fong HK, et al.. Racial and sex disparities in resource utilization and outcomes of multi-vessel percutaneous coronary interventions (a 5-year nationwide evaluation in the United States). Cardiovasc Diagn Ther. 2019, 9:18-29. 10.21037\/cdt.2018.09.02","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e318215d5e2","article-title":"Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada","volume":"49","author":"Austin PC","year":"2011","unstructured":"Austin PC, van Walraven C, Wodchis WP, Newman A, Anderson GM. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011, 49:932-9. 10.1097\/MLR.0b013e318215d5e2","journal-title":"Med Care"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-7","article-title":"An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan","volume":"8","author":"Chang HY","year":"2010","unstructured":"Chang HY, Weiner JP. An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan. BMC Med. 2010, 8:7. 10.1186\/1741-7015-8-7","journal-title":"BMC Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2012.009","article-title":"Predictors of sepsis in moderately severely injured patients: an analysis of the National Trauma Data Bank","volume":"14","author":"Kisat M","year":"2013","unstructured":"Kisat M, Villegas CV, Onguti S, et al.. Predictors of sepsis in moderately severely injured patients: an analysis of the National Trauma Data Bank. Surg Infect (Larchmt). 2013, 14:62-8. 10.1089\/sur.2012.009","journal-title":"Surg Infect (Larchmt)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181dcf36e","article-title":"Postoperative sepsis in the United States","volume":"252","author":"Vogel TR","year":"2010","unstructured":"Vogel TR, Dombrovskiy VY, Carson JL, Graham AM, Lowry SF. Postoperative sepsis in the United States. Ann Surg. 2010, 252:1065-71. 10.1097\/SLA.0b013e3181dcf36e","journal-title":"Ann Surg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw295","article-title":"Inpatient mortality among solid organ transplant recipients hospitalized for sepsis and severe sepsis","volume":"63","author":"Donnelly JP","year":"2016","unstructured":"Donnelly JP, Locke JE, MacLennan PA, et al.. Inpatient mortality among solid organ transplant recipients hospitalized for sepsis and severe sepsis. Clin Infect Dis. 2016, 63:186-94. 10.1093\/cid\/ciw295","journal-title":"Clin Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1688501","article-title":"Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis","volume":"39","author":"Shah A","year":"2019","unstructured":"Shah A, Crawford D, Burger D, et al.. Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis. Semin Liver Dis. 2019, 39:432-41. 10.1055\/s-0039-1688501","journal-title":"Semin Liver Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-017-5746-z","article-title":"Predictive risk factors associated with cholangitis following ERCP","volume":"32","author":"Tierney J","year":"2018","unstructured":"Tierney J, Bhutiani N, Stamp B, Richey JS, Bahr MH, Vitale GC. Predictive risk factors associated with cholangitis following ERCP. Surg Endosc. 2018, 32:799-804. 10.1007\/s00464-017-5746-z","journal-title":"Surg Endosc"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007345.pub2","article-title":"Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography","author":"Brand M","year":"2010","unstructured":"Brand M, Bizos D, O'Farrell P Jr. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography. Cochrane Database Syst Rev. 2010, CD007345. 10.1002\/14651858.CD007345.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007345","article-title":"Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography","volume":"10","author":"Brand M","year":"2010","unstructured":"Brand M, Bizos D, O'Farrell PJR. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography. Cochrane Database Syst Rev. 2010, 10:7345. 10.1002\/14651858.CD007345","journal-title":"Cochrane Database Syst Rev"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000044","article-title":"Outcomes in patients with cirrhosis on primary compared to secondary prophylaxis for spontaneous bacterial peritonitis","volume":"114","author":"Bajaj JS","year":"2019","unstructured":"Bajaj JS, Tandon P, O\u02bcLeary JG, et al.. Outcomes in patients with cirrhosis on primary compared to secondary prophylaxis for spontaneous bacterial peritonitis. Am J Gastroenterol. 2019, 114:599-606. 10.14309\/ajg.0000000000000044","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/253489-preventive-antibiotic-use-and-complications-after-endoscopic-retrograde-cholangiopancreatography-in-patients-hospitalized-for-primary-sclerosing-cholangitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T19:44:23Z","timestamp":1720813463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/253489-preventive-antibiotic-use-and-complications-after-endoscopic-retrograde-cholangiopancreatography-in-patients-hospitalized-for-primary-sclerosing-cholangitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.64429","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}